Large-scale testing (Phase 3)Study completedNCT00391131What this trial is testingSubcutaneous Ig NextGen 16% in PID PatientsWho this might be right forPrimary Immunodeficiency (PID) CSL Limited 35
Early research (Phase 1)Study completedNCT00092937What this trial is testingUse of Busulfan as Conditioning Agent for a Second Stem Cell TransplantWho this might be right forGranulomatous DiseaseChronic National Institute of Allergy and Infectious Diseases (NIAID) 2
Not applicableUnknownNCT01354587What this trial is testingEvaluation of Efficacy and Tolerability of Hizentra®Who this might be right forPrimary Immunodeficiency Disorders University of South Florida 50
Not applicableStudy completedNCT00000665What this trial is testingStudies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir ComponentWho this might be right forCytomegalovirus RetinitisHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 240
Large-scale testing (Phase 3)Study completedNCT02269163What this trial is testingStudy of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%Who this might be right forPrimary Immunodeficiency Prometic Biotherapeutics, Inc. 82
Not applicableLooking for participantsNCT00055172What this trial is testingGenetic Basis of ImmunodeficiencyWho this might be right forSevere Combined Immunodeficiency National Heart, Lung, and Blood Institute (NHLBI) 100
Not applicableStudy completedNCT00002299What this trial is testingThe Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDSWho this might be right forCytomegalovirus RetinitisHIV Infections Hoffmann-La Roche
Testing effectiveness (Phase 2)Study completedNCT00176865What this trial is testingStem Cell Transplant for Immunologic or Histiocytic DisordersWho this might be right forHemophagocytic LymphohistiocytosisX-Linked Lymphoproliferative DisordersChediak-Higashi Syndrome+3 more Masonic Cancer Center, University of Minnesota 19
Not applicableStudy completedNCT03029728What this trial is testingBiomarker for Hereditary AngioEdema DiseaseWho this might be right forC1 Esterase Inhibitor DeficiencyAngio EdemaC4 Deficiency+5 more CENTOGENE GmbH Rostock 42
Large-scale testing (Phase 3)Looking for participantsNCT07298447What this trial is testingDonidalorsen Treatment in Children With Hereditary AngioedemaWho this might be right forHereditary Angioedema (HAE) Ionis Pharmaceuticals, Inc. 20
Large-scale testing (Phase 3)Study completedNCT00462709What this trial is testingOpen-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) AttacksWho this might be right forHereditary Angioedema Shire 146
Testing effectiveness (Phase 2)Looking for participantsNCT07371663What this trial is testingAn Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid TumorsWho this might be right forSolid CancersNSCLC (Advanced Non-small Cell Lung Cancer)Gastric (Stomach) Cancer+2 more Beijing Tide Pharmaceutical Co., Ltd 266
Not applicableEnded earlyNCT02926963What this trial is testingGeneration of Powerful Biological Tools for Understanding the Pathophysiology of Chronic Granulomatous Disease.Who this might be right forChronic Granulomatous Disease University Hospital, Grenoble 3
Testing effectiveness (Phase 2)Study completedNCT01826916What this trial is testingEDEMA2: Evaluation of DX-88's Effect in Mitigating AngioedemaWho this might be right forHereditary Angioedema (HAE) Shire 77
Not applicableNot Yet RecruitingNCT06519734What this trial is testingPrimitive Immunodeficiency, Intrauterine Devices and Menstrual Hygiene ProductsWho this might be right forPrimary Immune Deficiency Diseases Assistance Publique - Hôpitaux de Paris 200
Not applicableStudy completedNCT03716700What this trial is testingReal-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)Who this might be right forPrimary Immunodeficiency Diseases (PID) Baxalta now part of Shire 126
Post-approval studies (Phase 4)Study completedNCT04566692What this trial is testingEvaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Participants and Loading/Maintenance Dosing in Treatment-Naïve Participants With Primary ImmunodeficiencyWho this might be right forPrimary Immunodeficiency Grifols Therapeutics LLC 33
Not applicableStudy completedNCT00002257What this trial is testingControlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDSWho this might be right forCytomegalovirus RetinitisHIV Infections Hoffmann-La Roche 150
Not applicableUnknownNCT01175239What this trial is testingGene Therapy for X-linked Severe Combined Immunodeficiency (SCID-X1)Who this might be right forX-linked Severe Combined Immunodeficiency Great Ormond Street Hospital for Children NHS Foundation Trust 1
Post-approval studies (Phase 4)Study completedNCT02881437What this trial is testingIgG Level in Primary Immunodeficiency Switching From Standard SCIG to Every Other Week HyQviaWho this might be right forPrimary Immunodeficiency University Hospital, Lille 22